Consistent with our findings, a prior study investigating potential serum biomarkers for FSHD in a small cohort of 23 patients and age-matched controls reported elevated MMP9 levels in patient serum (56). Here, MMP9 is linked to facioscapulohumeral muscular dystrophy.